Apolipoprotein D 抗体

Kuiperij, Hondius, Kersten, Versleijen, Rozemuller, Greenberg, Schreuder, Klijn, Verbeek: "Apolipoprotein D: a potential biomarker for cerebral amyloid angiopathy." in: Neuropathology and applied neurobiology, Vol. 46, Issue 5, pp. 431-440, (2020) (PubMed).

Flores, Jin, Chang, Zhang, Cogan, Schaefer, Kruth: "LCAT, ApoD, and ApoA1 Expression and Review of Cholesterol Deposition in the Cornea." in: Biomolecules, Vol. 9, Issue 12, (2019) (PubMed).

Herzig, Leppäluoto, Jokelainen, Meugnier, Pesenti, Selänne, Mäkelä, Ahola, Jämsä, Vidal, Keinänen-Kiukaanniemi: "Low level activity thresholds for changes in NMR biomarkers and genes in high risk subjects for Type 2 Diabetes." in: Scientific reports, Vol. 7, Issue 1, pp. 11267, (2019) (PubMed).

Braesch-Andersen, Beckman, Paulie, Kumagai-Braesch: "ApoD mediates binding of HDL to LDL and to growing T24 carcinoma." in: PLoS ONE, Vol. 9, Issue 12, pp. e115180, (2016) (PubMed).

Chen, Li, Du, Cao, Li: "Increased JNK1 activity contributes to the upregulation of ApoD in the apocrine secretory gland cells from axillary osmidrosis." in: Molecular and cellular biochemistry, Vol. 354, Issue 1-2, pp. 311-6, (2011) (PubMed).

Thomas, Dean, Pavey, Sutcliffe: "Increased CNS levels of apolipoprotein D in schizophrenic and bipolar subjects: implications for the pathophysiology of psychiatric disorders." in: Proceedings of the National Academy of Sciences of the United States of America, Vol. 98, Issue 7, pp. 4066-71, (2001) (PubMed).